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Abstract
Latent HIV infection of long-lived cells is a barrier to viral clearance. Hematopoietic stem
and progenitor cells are a heterogeneous population of cells, some of which are long-lived.
CXCR4-tropic HIVs infect a broad range of HSPC subtypes, including hematopoietic stem
cells, which are multi-potent and long-lived. However, CCR5-tropic HIV infection is limited to
more differentiated progenitor cells with life spans that are less well understood. Consistent
with emerging data that restricted progenitor cells can be long-lived, we detected persistent
HIV in restricted HSPC populations from optimally treated people. Further, genotypic and
phenotypic analysis of amplified env alleles from donor samples indicated that both CXCR4-
and CCR5-tropic viruses persisted in HSPCs. RNA profiling confirmed expression of HIV
receptor RNA in a pattern that was consistent with in vitro and in vivo results. In addition, we
characterized a CD4high HSPC sub-population that was preferentially targeted by a variety
of CXCR4- and CCR5-tropic HIVs in vitro. Finally, we present strong evidence that HIV pro-
viral genomes of both tropisms can be transmitted to CD4-negative daughter cells of multi-
ple lineages in vivo. In some cases, the transmitted proviral genomes contained signature
deletions that inactivated the virus, eliminating the possibility that coincidental infection
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explains the results. These data support a model in which both stem and non-stem cell pro-
genitors serve as persistent reservoirs for CXCR4- and CCR5-tropic HIV proviral genomes
that can be passed to daughter cells.
Author summary
People who are effectively treated with antiretroviral medication harbor persistent forms
of HIV that are integrated into the cellular genome. While HIV is cytopathic to most cells,
transcriptionally silent, latent forms do not express toxic HIV gene products and can sur-
vive in the host for years. When conditions change, the latent virus can be activated to
reinitiate infection. Because of the capacity for virus to spread, cure of HIV will require
that we identify and eradicate all cells harboring functional HIV provirus. CD4+ T cells
are abundant and easily identified as harboring proviral genomes. However, rare cell
types that express HIV receptors, such as bone marrow hematopoietic progenitor and
stem cells can also be infected by the virus potentially serving as barriers to cure strategies.
We found that HIV can infect and persist in progenitor sub-types that were previously
thought to be short lived, which expands the types of cells that can support reservoir for-
mation. In addition, we found that HIV can spread by proliferation and cellular differenti-
ation without the need for viral gene expression and virion production that could reveal
the infection to the immune system. A deeper understanding of viral reservoirs is critically
important for developing strategies that will succeed in viral eradication.
Introduction
Long term combination anti-retroviral therapy (cART) blocks viral spread in vivo but is not
curative, as plasma virus rebounds after cART interruption. Sequence analysis of residual cir-
culating and rebounding virus in HIV+ patients indicates that virions likely come from the
activation of latent provirus that had been archived since before the initiation of therapy rather
than from low-level replication and spread of cART-resistant virus [1, 2].
HIV enters cells via HIV Env interacting with CD4 plus a co-receptor, usually CCR5 or
CXCR4. CXCR4-utilizing viruses differ from those that utilize CCR5 in their ability to infect
stem cells that can engraft and generate multiple lineages in a mouse xenograft model [3]. In
contrast, CCR5-tropic viruses infect HSPCs that are restricted in their capacity to differentiate
[3]. Recently, Nixon and colleagues elegantly demonstrated that myeloid progenitors, includ-
ing common myeloid progenitors (CMPs) and granulocyte/monocyte progenitors (GMPs),
express CCR5 and can be infected by CCR5-tropic HIV in vitro and in a humanized mouse
model [4].
Based largely on patterns of hematopoiesis that occur following transplantation, hemato-
poietic progenitors, such as those targeted by CCR5-tropic HIVs, were thought to be short-
lived in vivo [3–5]. However, in situ tagging experiments in mice have recently found that
non-stem cell progenitors make an enduring contribution to native hematopoiesis in adults
through successive recruitment of thousands of clones, each with a minimal contribution to
mature progeny [6–8]. Consistent with this, non-stem cell myeloid progenitors such as GMPs
were found to persist in people with aplastic anemia despite dramatic losses of stem cells [6].
Thus, a large number of long-lived progenitors, rather than classically defined Hematopoietic
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stem cells (HSCs), may be the main drivers of steady-state hematopoiesis during adulthood
[7, 8].
Here, we provide evidence that non-stem cell hematopoietic progenitors harbor CCR5-tro-
pic HIVs for years in optimally treated people, providing new evidence that non-stem cell pro-
genitors are long-lived in people without evidence of bone marrow disease and can potentially
serve as reservoirs of HIV. We also demonstrate that CD4high HSPC subsets that we show
include multi-potent progenitors (MPPs) are preferentially targeted by both HIV subtypes
in vitro. Moreover, we provide in vivo evidence that infected HSPCs can differentiate into
multiple lineages that harbor provirus. These data expand our understanding of HIV infection
and hematopoiesis by demonstrating that in addition to stem cells, intermediate progenitor
cells potentially provide an enduring reservoir for CCR5- and CXCR4-tropic HIV proviral
genomes.
Results
Isolation of stem-cell-enriched and depleted HSPC populations from
patient samples
To better understand the types of hematopoietic stem and progenitor cells (HSPCs) that are
infected by HIV in vivo, we developed an approach to efficiently isolate HSPC populations
enriched (Sort 1) or depleted (Sort 2) for stem cells (Fig 1A and 1B). Compared to Sort 1 cells,
Sort 2 cells expressed lower levels of CD133 (Fig 1B) and were depleted for hematopoietic stem
cells (HSCs) and multi-potent progenitors (HSC/MPPs) (Fig 1C–1G). Conversely, Sort 2 cells
were enriched for more restricted progenitors (common myeloid progenitors (CMPs) and
megakaryocyte/erythrocyte progenitors (MEPs) (Fig 1H and 1I)[9]. Enrichment of MEPs in
Sort 2 samples was confirmed using methylcellulose colony formation assays (Fig 1J).
To develop a better understanding of which HSPCs harbor HIV in vivo, we obtained sam-
ples from 47 HIV-infected donors, including two that had been initially treated during acute
infection. All donors were on therapy with undetectable viral loads for least six months. A 20
ml bone marrow sample and 100 ml of peripheral blood were collected from each donor.
HSPCs were isolated from adherence depleted bone marrow mononuclear cells in two steps as
described in Fig 1. From 20 cc of bone marrow, we obtained ~2.5x106 total HSPCs per donor.
For 41 of 47 donors, we obtained adequate aspirates and the purified HSPCs met our criteria
of having<1% CD3+ T cell contamination and>80% CD34+ or CD133+ cells. The mean
purity of included samples was approximately 94% CD133 for Sort 1 and 90% CD34 for Sort 2
(Table 1, S1 and S2 Tables).
DNA was isolated from each sample and multiplex single genome amplification (SGA)
polymerase chain reaction (PCR) was used to amplify gag and env amplicons or near full-
length genomes. For each donor, we selected a primer pair combination that most efficiently
amplified HIV sequences from peripheral blood mononuclear cell (PBMC) DNA prior to test-
ing HSPC samples. After analyzing at least 80,000 cells from all samples that met our purity
criteria, we determined that most donors (n = 24, 59%) had detectable HIV provirus in
HSPCs. More cells were screened in the positive group than in the undetectable group
(975,959 versus 661,965) but that difference and the level of sample purity between the two
groups were not statistically significant (Table 1). Further, the timing of HAART was not a sig-
nificant factor in our ability to detect provirus; one of two donors treated since acute infection
had detectable HSPC-associated provirus and provirus was present in long term suppressed
patients (up to 9.8 years, Table 1). The overall mean frequency of provirus in HSPCs was 2.4
copies per million cells based on the number of positive 1st round PCR reactions (82) set up at
limiting dilution that produced a gag and/or env amplicon out of the total number of cells
HIV infection of hematopoietic progenitors
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Fig 1. Sort 2 HSPCs are depleted for HSCs. A. Diagrammatic representation of HSPC purification. FT, column flow-through; CB, cord
blood; BMMC, bone marrow mononuclear cells. B. Representative flow cytometric analysis of HSPC samples from an HIV+ individual. C.
Gates for each HSPC population phenotype and lineage output according to Doulatov et al [9]. (HSC, hematopoietic stem cell; MPP,
multipotent progenitor; MLP, multilymphoid progenitor; CMP, common myeloid progenitor; MEP, megakaryocyte/erythrocyte progenitor;
GMP, granulocyte/monocyte progenitor; B-NK, B and NK cell progenitor; MDC, macrophage and dendritic cell; EMK, erythroid and
megakaryocyte; G, granulocyte.) D. Representative flow cytometric analysis of differentiation markers expressed on bone marrow HSPCs
purified as described in A. For the two right-most panels, numbers indicate percentage of total CD34+ events from each sort falling into that
gate. E. Flow cytometric plot comparing relative numbers of HSCs (CD34+CD38- cells that are also CD90+) in Sort 1 versus Sort 2. F-I.
Summary graph showing the relative frequency of the indicated progenitor in each sort, n = 3 uninfected donors. To facilitate comparison,
results were normalized to Sort 2 (F and G) or Sort 1 (H—I). Mean ± standard deviation is indicated. J. Summary plots of methylcellulose
colony formation assays from three uninfected donors. Mean ± standard deviation is indicated. Colony forming unit (CFU)-E, erythroid;
CFU-GM, granulocyte/macrophage and CFU-GEMM, multilineage. (*p<0.05 and **p<0.01, 2-tailed Student’s t-test).
https://doi.org/10.1371/journal.ppat.1006509.g001
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assayed (35 million). For individual donors, the frequency ranged from <1 per 1.3 x106 cells to
18 copies per 106 cells.
Frequency of replication competent virus. To assess the frequency of replication com-
petent virus amongst the proviral DNA that could be amplified from HSPCs, we utilized
primers that generated near full–length (approximately 9000 base pair) amplicons. From a
total of 14 reactions that generated amplicons using these primers (S2 Table), subsequent
analysis identified four with intact open reading frames and cis elements (S3 Table), sug-
gesting that approximately 30% of proviral genomes in HSPCs are likely to be functional.
All amplicons were directly sequenced from the purified gel band and screened to
ensure they were not identical to sequences from other donors or molecular clones used in
the lab (S1 Fig). The amplified near full-length proviral genomes came from highly purified
HSPCs (Fig 2A) and were unlikely to have been derived from CD3+ T cells (see below and
Fig 2).
CD3+ T cells are an unlikely source of HIV DNA in HSPC samples
To rule out T cells as a source of HIV DNA in HSPC samples, we eliminated all HSPC samples
with>1% contaminating CD3+ cells and all samples included in our final analysis contained
<0.52% CD3+ cells (S1 and S2 Tables).
In addition, we used a previously published statistical method that takes into account HIV
genome frequency in sorted and flow-through samples, assigning a p value to indicate the like-
lihood that HIV DNA in HSPC samples came from T cells [10]. This analysis is shown in detail
in Fig 2. Briefly, we carefully assessed the frequency of CD3+ T cells and provirus in both the
sorted sample and in the flow-through sample. Then, we compared the frequencies assuming
that only CD3+ T cells account for all provirus. As shown in Fig 2B, the frequency of infected
CD3+ T cells would have to have been much higher in the sorted sample than in the flow-
through to account for the provirus in the sorted HSPC samples (e.g. 1 in 52 versus 1 in 15,000
Table 1. Donor characteristics.
HSPC proviral DNA Positive Below the limit of detection
Number of donors 24(59%) 17 (41%)
Number treated since acute infection 1 (50%) 1 (50%)
Male 21 15
Female 3 2
Black 3 4
White 21 13
Non-Hispanic 22 17
Hispanic 2 0
CD4 count (mean) 849 678
CD4 count (range) 215–2060 308–1112
Viral load <48 <48
Duration of suppression, years (mean) 3.6 4.4
Range of suppression, years 0.5–9.8 0.6–11.1
Mean Sort 1 purity (% CD133, % CD3) 94.7, 0.31 93.1, 0.32
Mean Sort 2 purity (% CD34, % CD3) 90.5, 0.21 89.9, 0.22
Mean number of cells screened (per donor) 975,949 661,965
Range of cells screened 167,375–3,208,600 83,070–1,300,000
https://doi.org/10.1371/journal.ppat.1006509.t001
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for donor 409000). This difference is assigned a p value that takes into account 95% confidence
intervals and only samples with p<0.05 were included in our final analysis.
Consistent with our conclusion that HIV DNA from Sort 1 and 2 came from HSPCs
and not CD3+ T cells, we observed no correlation between proviral frequency in the
samples and the frequency of contaminating CD3+ cells (S2 Fig). In addition, rearranged T
cell receptor PCR assays were performed to confirm that near-full-length genomes from
HSPC DNA samples were unlikely to have originated from T cells (Fig 2C). Similar results
were obtained from donor 413402, which was screened by PCR because too few cells were
available to accurately assess this sample by flow cytometry (S4 Table, S3 Fig). [The caveats
for the rearranged TCR PCR assay are that it is not quantitative and it is associated with
non-specific background bands that limit the amount of DNA that can be added to the
reaction. These non-specific bands arise in all samples, including negative control HEK
293 cells, and are not related to TCR based on sequencing analysis. Because of these limita-
tions, the statistical analysis we described in Fig 2 provides a more robust and quantitative
assessment.]
Fig 2. Near-full-length HIV provirus in HSPCs preparations is unlikely to be from T cell contamination. A. Flow cytometric analysis of
HSPCs from three donors that harbored near full-length genomes. Numbers indicate the frequency of events falling into each quadrant.
CD133 or CD34 were assessed for Sort 1 or Sort 2 respectively. B. Summary table showing data for Fisher’s exact test, which compares
calculated frequencies of provirus assuming all provirus originates from T cells. PCRs were performed at limiting dilution. Significantly
discrepant frequencies in sorted and flow-through samples indicate T cells are an unlikely source of provirus in sorted samples.
Conservative estimate compares the top of the 95% confidence interval for the calculated infection rate for flow-through CD3+ T cells with
the bottom of the 95% confidence interval for the calculated infection rate for CD3+ T cells in the sorted HSPCs. C. Agarose gel analysis of
rearranged T cell receptor gene PCR. 50, 100 or 200 cell equivalents of DNA from the first round PCR reaction that yielded each provirus
were added to each reaction. For “T cells”, 200 cell equivalents of DNA from purified CD4+ T cells were added to the reaction. The expected
size of the amplicons is 250–300 bp. Numbers to the left of each gel indicate the location of molecular weight markers.
https://doi.org/10.1371/journal.ppat.1006509.g002
HIV infection of hematopoietic progenitors
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Both CCR5 and CXCR4-tropic HIVs persist in bone marrow HSPCs
Based on initial results that CCR5-tropic HIVs infect non-stem-cell progenitors that were orig-
inally believed to be short lived, we expected to mainly observe CXCR4-tropic virus in HSPC
preparations. To assess this, we examined env amplicons available to study from a subset of 19
donors from the overall cohort. As summarized in Tables 2 and 3, we isolated a total of 52 env
C2-V3 amplicons. Each amplicon was assigned a genotype using the indicated co-receptor
prediction software (Table 3). 16 amplicons from 8 donors were predicted to be CXCR4-tro-
pic, including three near-full-length genomes with full open reading frames and cis elements
(S3 Table). Unexpectedly, we also isolated a total of 36 amplicons from 17 donors that were
predicted to be CCR5-tropic, including one near-full-length genome with full open reading
frames and cis elements (S3 Table). Overall, the genotopyes of env amplicons from HSPCs
closely matched those from peripheral blood mononuclear cells for each donor (Table 3).
Because env genotype prediction tools are not always reliable, we confirmed Env tropism
with a phenotypic assay. For this analysis, we used either HSPC-derived full-length Env or a
non-HSPC-derived Env with identical nucleotide or amino acid V3 region from the same
donor as available (Table 4). A phenotypic assay utilizing 3T3 cells expressing CD4 and indi-
vidual chemokine receptors [11] was used for this assessment. This assay confirmed the tro-
pism of ten CCR5-tropic Envs, four CXCR4/dual tropic Envs and demonstrated that one Env
was not functional. The isolation of HIV encoding Envs of both tropisms from HSPCs suggests
either that CCR5-tropic Envs unexpectedly target HSCs or that restricted progenitor cells tar-
geted by CCR5-tropic viruses survive longer in vivo than expected.
Evidence that restricted progenitors targeted by CCR5-tropic viruses
persist in vivo
To better understand whether CCR5-tropic viruses might target restricted progenitors that
persist longer than expected, we asked whether provirus could be detected in Sort 2, which
contained restricted progenitors that were unlikely to be stem cells. Interestingly, we found no
significant difference in the number of donors with amplicons in Sort 1 versus Sort 2 subsets
[14 donors had amplicons isolated from Sort 1 and 11 had amplicons isolated from Sort 2,
(Tables 2 and 3)]. The mean frequency of env amplicons was higher in Sort 1 than Sort 2 but
this difference did not achieve significance. (The mean frequency was four copies per million
cells for Sort 1 versus two copies per million cells for Sort 2, p = 0.06.) None of the amplicons
isolated from Sort 2 were identical to those from Sort 1, indicating that independent infection
of restricted progenitors rather than differentiation of infected stem cells explains the presence
of provirus in this population. In sum, these results suggest that non-stem cell restricted
HSPCs can be infected by HIV and endure for at least the period of effective antiretroviral
treatment.
Table 2. Summary of donor env amplicons in Sort 1 and 2 HSPCs.
Number of donors with C2-V3 env amplicons 19
Number C2-V3-env amplicons amplified from HSPCs 52
Donors with CXCR4-tropic Env in HSPCs 8
Donors with CCR5-tropic Env in HSPCs 17
Donors with proviral genomes of both tropisms in HSPCs 6
Donors with provirus in stem cell enriched fraction (Sort 1) 14
Donors with provirus in progenitors depleted for stem cells (Sort 2) 11
Donors with provirus in both HSPC populations 6
https://doi.org/10.1371/journal.ppat.1006509.t002
HIV infection of hematopoietic progenitors
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Table 3. Analysis of env amplicons isolated from HIV+ donors.
Donor ID
(% purity)
(S1, S2)
HSPC Sort 1 (S1) HSPC Sort 2 (S2) PBMC
env amplicons env amplicons env amplicons
# FPR Genob Phenoc # FPR Geno Pheno # FPR Geno
409000(98, 98) 1****w
1****w
1*w
61
0.7
0.7
R5
X4/Dual
X4/Dual
ND 17
11
38–61
0.7
R5
X4/Dual
413402
(94, 91)
1* 1.7 X4/Dual Dual ND 6 1.7 X4/Dual
414000
(95, 85)
1* 57 R5 R5 ND 5 57 R5
415000
(95, NA)
1** 71 R5 R5 NA 20 43–83 R5
419000
(95, NA)
1*** 89 R5 NA 21 22–99 R5
420000
(99, 92)
1****
1****w
1****
1****w
19
73
0.7
8.1
R5
R5
X4/Dual
X4/Dual
R5
Dual
ND 11
7
14–73
0.5–1.7
R5
X4/Dual
421000
(99, 96)
1***w
2***
7.8
7.4,7.8
X4/Dual
X4/Dual X4
1**w 7.8 X4/Dual 4
5
24–94
4.7–9.6
R5
X4/Dual
426000
(97, 92)
ND 4****
2****w
1****w
29–60
20–31
4.8
R5
R5
X4/Dual
10
1
20–38
3.2
R5
X4/Dual
428408
(95, 86)
(91, 91)
2****
1****
83,84
1.3
R5
X4/Dual 1**w 1.3 X4/Dual
22
16
30–100
0.7–6.8
R5
X4/Dual
431000
(93, 89)
2****
1****
75
79
R5
R5
R5
R5
ND 8 38–90 R5
432000
(98, 99)
1****
1****
17
2.8
R5
X4/Dual X4 1****
1****
2.8
3.4
X4/Dual
X4/Dual
NF
1
8
1
11
4
49
3.4–8.5
74
2.8–4.7
3.4–8.5
R5
X4/Dual
R5
X4/Dual
X4/Dual
434423
(92, 89)
(94, 84)
1** 38 R5 1** 46 R5 18 38–82 R5
435412406
(99, 99)
(98, 83)
(95, 94)
1**
2****
1**
1**w
83
87
89
45
R5
R5
R5
R5
R5
R5
R5 1** 83 R5 R5 103 42–99 R5
436000
(93, 85)
ND 2** 31 R5 R5 8 31–85 R5
437000
(94, 92)
1** 55 R5 ND 8 12–55 R5
449000
(90, 95)
1* 100 R5 1** 81 R5 5 59–99 R5
453000
(96, 83)
ND 1*** 74 R5 R5 6 41–86 R5
454304
(92,93)
ND 1*
1*w
31
9.6
R5
X4/Dual
24
1
11–97
6.8
R5
X4/Dual
(Continued)
HIV infection of hematopoietic progenitors
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CD4, CCR5 and CXCR4 RNA are expressed in a variety of HSPC
subsets
The result that HSPCs depleted of HSCs harbor HIV provirus that persists in optimally treated
people as well as the finding that CCR5-utilizing virus persists in HSPCs was unexpected;
Table 3. (Continued)
Donor ID
(% purity)
(S1, S2)
HSPC Sort 1 (S1) HSPC Sort 2 (S2) PBMC
env amplicons env amplicons env amplicons
# FPR Genob Phenoc # FPR Geno Pheno # FPR Geno
456000
(93,90)
ND 3**** 13–39 R5 10
2
10.5–39
7.4, 9.2
R5
X4/Dual
# indicates the number of amplicons of that type isolated from each donor.
bgenotypic prediction of co-receptor usage by Geno2pheno using a false positive rate (FPR) cutoff of10% [36, 37].
cphenotypic analysis of co-receptor usage (see Table 4).
“w” indicates amplicons from whole genome PCR and black text indicates amplicons from multiplex PCR reaction.
Asterisks reflect the likelihood that CD3+ T cells contamination was responsible for the amplicon
*p < 0.05 by (1) only
**p < .05 by (1) and (2)
***p < .01 by (1) and (2)
****p < .001 by (1) and (2) where (2) is using the more conservative assessment (Fig 2) [10].
Abbreviations: HSPC, hematopoietic stem and progenitor cells; PBMC, peripheral blood mononuclear cells; NA, not analyzed due to purity concerns; R5,
CCR5; X4, CXCR4; ND, not detectable; NF, non-functional.
Each set of three non-zero numbers in the donor name represents an independent donation.
https://doi.org/10.1371/journal.ppat.1006509.t003
Table 4. Summary of Env phenotypes with V3 regions matching HSPC-associated env sequences.
Donor ID Source of full length Env Amplicon Source of Matching V3 Amplicon FPR Genotype Phenotype
413402 PBMC Sort 1 1.7 X4/Dual Dual
414000 PBMC Sort 1 57 R5 R5
415000 HSPC Sort 1 71 R5 R5
420000 PBMC Sort 1 19 R5 R5
420000 PBMC Sort 1 0.7 X4/Dual Dual
421000 HSPC Sort 1 7.8 X4/Dual X4
431000 Sort 1 FT Sort 1 75 R5 R5
431000 PBMC Sort 1 79 R5 R5
432000 HSPC Sort 1 2.8 X4/Dual X4
432000 HSPC Sort 2 2.8 X4/Dual NF
435412406 PBMC Sort 1 83 R5 R5
435412406 PBMC Sort 1 87 R5 R5
435412406 PBMC Sort 1 89 R5 R5
436000 PBMC Sort 2 31 R5 R5
453000 PBMC Sort 2 74 R5 R5
Abbreviations: FT, flow-through; NF, non-functional Env; FPR, false positive rate from Geno2pheno.
Each set of three non-zero numbers in the donor name represents an independent donation.
https://doi.org/10.1371/journal.ppat.1006509.t004
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therefore, we pursued additional evidence to better understand this finding. First, we assessed
expression of HIV receptors in HSPC subsets. To accomplish this, we used a publicly available
microarray dataset of RNA expression in human bone marrow HSPCs [12] and used estab-
lished markers to purify murine bone marrow HSPCs for an RNA-seq analysis to profile
expression of HIV receptors in HSPC subtypes. After confirming that progenitor subsets from
each species expressed the expected developmentally appropriate set of genes (Fig 3) we found
that both approaches yielded similar results. As shown in Fig 3, both revealed very low CCR5
expression in HSCs with higher expression in some restricted hematopoietic progenitor sub-
types. These results agree with published studies showing low or no expression of CCR5 pro-
tein by HSC-enriched cells [3, 13] with more expression of CCR5 protein in restricted hemato-
poietic progenitor sub-populations [4, 13]. In addition, both approaches showed that CXCR4
and CD4 RNA were expressed by HSCs and several other progenitor populations (Fig 3).
Based on this analysis, CXCR4-tropic viruses are predicted to target a wide range of progenitor
subsets including HSCs whereas CCR5-tropic Envs are more likely to target restricted HSPC
subsets such as GMPs.
Fig 3. Expression of HIV receptors in progenitor cells. A. Affymetrix array data of gene expression in human bone marrow stem and
differentiated cell types extracted from a published data set [12] accessed via the NCBI Gene Expression Omnibus database (GSE42519).
Left panel, heat map representing the z-score (scaled for each column) of the log transformed gene expression data. Right panel, relative
expression levels of HIV receptors in each subset. The original microarray data went through background correction, normalization, and log
transformation via the RMA method. For the right panel, data was converted from log transformed to linear. B. RNA seq analysis of mouse
bone marrow and differentiated cell types. Left panel, heat map representing the z-score (scaled for each column) of the log transformed
gene expression data. Right panel, relative expression levels of HIV receptors in each subset. Mean ± SEM is shown. (Abbreviations: FC,
fold change; HSC, hematopoietic stem cell; MPP, multipotent progenitor; CMP, common myeloid progenitor; GMP, granulocyte-monocyte
progenitor; MEP, megakaryocyte-erythrocyte progenitor; PM, promyelocyte; MY, myelocyte; MM, metamyelocytes; BC, band cell; PMN,
polymorphonuclear cells; GR, granulocyte; ProB, pro-B cell; PreB, pre-B cell; BM, unfractionated bone marrow. FPKM, Fragments Per
Kilobase Of Exon Per Million Fragments Mapped) (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, 2-tailed unpaired t test).
https://doi.org/10.1371/journal.ppat.1006509.g003
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Full length and transmitter/founder CCR5-tropic HIVs target restricted
hematopoietic progenitors that are unlikely to be stem cells
In prior studies, we used pseudotyped lentiviral reporter constructs to examine differential
targeting of HSPCs by CCR5 and CXCR4 and it remained possible that full length, wild
type HIVs target cells differently. To examine this question, we compared HIV infection of
HSPCs by two wild type viruses, NL4-3 (CXCR4-tropic) and YU-2 (CCR5-tropic) (Fig 4A).
After demonstrating that CD133bright cell populations contain the majority of HSCs based
on CD38, CD45RA and CD90 staining (Fig 4B), we used the level of CD133 staining to
assess HIV infection of HSCs. As shown in Fig 4C, full length HIVs demonstrated the same
Fig 4. A. Schematic of full-length HIV used in C-E. B. Flow cytometric plots of CD133-sorted cord blood HSPCs cultured for 7 days and
stained as in Fig 1D. Cells gated in left plot were overlaid on the total live population on the right. C. Representative flow cytometric plots of
cord blood-derived CD133-sorted cells expanded for four days, infected with the indicated virus and harvested 2 days post-infection. Gag +
cells are overlaid onto CD34 versus CD133 plots for the total live cell population and the percentage of Gag+ cells in the CD133high and
CD133low regions is indicated in the overlay. D. Summary graph of relative CD133 expression by mean fluorescence intensity (MFI) on
HSPCs infected with the indicated HIV. Results were normalized to those for YU-2 infected cells for each experiment. E. Summary graph
showing the frequency of Gag+ cells falling into CD133bright gate. Data was compiled from four cord blood experiments; mean ± standard
deviation is indicated (****p < 0.0001, 2-tailed paired t-test).
https://doi.org/10.1371/journal.ppat.1006509.g004
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pattern as previously observed using pseudotyped lentiviral vectors; CCR5-tropic YU2
infected a restricted pattern of progenitors depleted of stem cells whereas NL4-3 targeted a
wide range of progenitors, including those likely to be stem cells. (Maraviroc and AMD3100
appropriately inhibited entry via CCR5 and CXCR4 respectively, Fig 4C, lower panels.) Cor-
respondingly, on average, we measured about 4.5 times more CD133 on HSPCs infected
by NL4-3 than those infected with YU2 (Fig 4D and 4E). Further, the same pattern was
observed using a lentiviral construct (HIV-7/SF-GFP) pseudotyped with additional Env
proteins including one from a CCR5-tropic transmitted/founder virus [SVPB16 (SV16)][3,
14, 15 (Fig 5). In sum, consistent with prior results, CCR5-tropic viruses consistently dem-
onstrated a restricted pattern of infection of more differentiated progenitors that contrasts
with the wide range of progenitors targeted by CXCR4-tropic and VSV-G-pseudotyped
viruses. Confirmation that a wide range of CCR5-tropic HIVs are restricted to non-stem
cell HSPCs suggests that the CCR5-tropic HIV we detected in stem cell–depleted HSPC
populations from patients likely came from more restricted progenitors that survived longer
than previously appreciated and that these cells might also serve as long lived cellular reser-
voirs of HIV.
CCR5- and CXCR4-utilizing viruses target a separable population of
multipotent HSPCs that have high levels of CD4
The HIV receptor, CD4, is usually required for infection and is expressed on CD34+ HSPCs,
although at low levels compared to CD4+ T cells [16, 17]. If the relative level of CD4 expres-
sion on HSPCs determined susceptibility of HSPCs to infection, then CD4 expression would
serve as an indicator of the subtypes of HSPCs potentially targeted by HIV. To examine
this question, we treated HSPCs with a GFP-expressing lentiviral vector pseudotyped with
CCR5- or CXCR4-tropic Env proteins (Fig 6A and 6B) and assessed CD4 levels on the GFP+
transduced cells. We observed that HSPCs within a CD4high flow cytometric gate displayed
2–30 times greater infection than CD4low/- cells (Fig 6A–6C). The increased infection of
CD4high cells was not due to a greater capacity of these cells to support infection by this virus
because the same virus pseudotyped with the vesicular stomatitis virus glycoprotein
(VSV-G) demonstrated no such preference (Fig 6B). Further, CCR5-tropic envelopes had a
significantly greater propensity to target CD4high progenitors compared to CXCR4 and dual-
tropic envelopes (Fig 6B and 6C). Thus, relative CD4 expression levels correlated with sus-
ceptibility of HSPCs to infection by HIV-1 and HSPCs that express higher levels of CD4 are
more likely to become infected.
Characterization of CD4+CD133+ and CD34+ cells
To determine whether CD4 marks a stable and separable progenitor subset with unique char-
acteristics, we used flow cytometry to determine whether HSPCs could be separated into low
and high CD4 expressing cells. Remarkably, sorting separated two distinct HSPC populations
with different levels of CD4 (Fig 7A). We then used these populations to demonstrate that
CD4high HSPCs could form GEMM, granulocyte/macrophage (GM), and erythroid (E) colo-
nies (Fig 7B). Thus, CD4 marks a subset of HSPCs that includes a number of different types of
progenitors, including multipotent progenitors capable of generating multi-lineage GEMM
colonies.
To examine the CD4high sub-population in more detail, we used cell surface markers that
had been validated with functional assays for HSPC subsets [9]. Remarkably, we found that
CD4high HSPCs in Sort 1 contained a significantly greater frequency of HSCs and MPPs
(CD38-CD10-CD45RA-) than CD4low HSPCs in the same Sort (Fig 8). Because CD133 also
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Fig 5. Targeting of intermediate progenitors by CCR5-tropic Envs is a conserved property extending to a transmitted/founder
virus. A. Schematic of HIV-7/SF-GFP construct and HIV envelope plasmid used to construct pseudotyped viruses used in C-E. B. Summary
table of envelope proteins used to pseudotype HIV-7/SF-GFP virus. C. Representative flow plots of cord blood-derived CD133-sorted cells
expanded for four days, transduced with the indicated virus and harvested 3 days post-infection for flow cytometric analysis. In each right
panel, GFP+ cells were overlaid onto plots of the total cell population and the percentage of GFP+ cells in the CD133high and CD133low
regions is indicated. Gates were determined based on isotype control antibody staining (top panel). D. Summary graph of CD133 MFI for
experiments performed as in C. Results are compiled from 11 cord blood experiments. Mean ± standard deviation is indicated; n3 for each
envelope. 2-tailed Student’s t-test indicates significance for each HIV envelope with respect to VSV-G (**p < 0.01,***p < 0.001,
****p < 0.0001). E. Data from (D) compiled by tropism. Mean ± standard deviation is indicated; one-way ANOVA, p = 0.0002, with Tukey’s
Multiple Comparisons Test indicated (**p < 0.01 and ***p < 0.001).
https://doi.org/10.1371/journal.ppat.1006509.g005
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Fig 6. HSPCs with greater CD4 expression are preferentially infected by HIV Envs. A. Representative flow cytometry
plots and gating strategy for cord blood-derived CD133-sorted cells infected with virus containing the indicated envelope
protein and harvested 3 days post-infection. Gating for CD4 was determined by the inclusion of 1% of cells stained with an
isotype control antibody (gray). For GFP plots, numbers indicate the percentage of GFP+ events. B. Summary graphs
depicting the ratio of infected cells in CD4high versus CD4low/- subsets of cord blood-derived HSPCs infected and analyzed
as in part A. For SV16, two replicates had 0.0% infection in the CD4low/- gate leading to an undefined ratio, so 30.0 was used
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marks populations enriched for HSCs, we confirmed this result by demonstrating that there
were significantly higher levels of CD4 on CD133high HSPCs than on CD133dim HSPCs (ratio
paired t test, p = 0.020). In contrast, Sort 1 CD4low/- HSPCs and all Sort 2 cells that had lower
levels of CD133 (including those that were relatively CD4high) were less frequently HSC/MPPs
and more frequently restricted progenitors such as CMP/MEPs (Fig 8). Similar results were
obtained whether or not lineage positive cells were depleted from the sample prior to analysis
(Fig 8C, open symbols). Thus, CD4 is expressed by a heterogeneous subset of hematopoietic
progenitors and is expressed at significantly higher levels on subsets that include HSCs and
MPPs.
Transmission of HIV provirus from progenitor cells to CD4-negative
progeny in vivo by proliferation and differentiation
If HIV infects progenitor cells in vivo, HIV genomes could theoretically be passed to differenti-
ated daughter cells as long as differentiation did not lead to reactivation of the virus from
latency and cell death. To determine whether HIV can be transmitted by differentiation of
infected progenitors, we assessed HIV proviral frequency in CD4-negative HSPC progeny.
(CD4-negative progeny were chosen for this analysis because cells lacking this HIV receptor
are unlikely to be directly infected.) To reduce the possibility of contamination by CD4-expres-
sing cells, we depleted CD4+ cells using an anti-CD4 magnetic bead column prior to fluores-
cence activated cell sorting (FACS). Following bead depletion and FACS, CD3+CD4+ T cells
were undetectable in most samples (Table 5). Moreover, lineage-positive cells (CD19+ B cells,
CD8+ T cells and CD56+ natural killer (NK) cells) were>98% CD4 negative (indicated as
“post-FACS” in Fig 9A).
To determine whether HIV proviral DNA was present in these lineages, we used multiplex
SGA PCR as described above. Remarkably, we generated a total of 38 LTR-gag or C2-V3env
amplicons from four of five donors with CXCR4-tropic HIV but only one of five donors with
only CCR5-tropic virus (Table 5). In two cases (donors 420000 and 431000), amplicons were
identical to those isolated from HSPCs (indicated as # in Table 5). These cells were highly puri-
fied with undetectable CD3+CD4+ T cells (Fig 9A and Table 5). Using a quantitative statistical
analysis, we found that the amplicons from CD4-negative lineages were unlikely to have come
from contaminating CD3+CD4+ T cells (p<0.05-p<0.001, Table 5). These results provide,
strong evidence that HIV provirus can be transmitted from infected progenitors to progeny
cells in vivo.
Although we only detected provirus in CD4-negative cells from one of five donors (431000)
with predominantly CCR5-tropic HIV, this donor provided the strongest evidence for HIV
infection of multi-potent progenitors. Indeed, using SGA PCR, we amplified 14 identical
CCR5-tropic C2-V3env amplicons from all three CD4-negative lineages, which were perfect
matches to one another as well as to an amplicon isolated from HSPCs [Figs 9B and 10A]. In
addition, seven first round SGA multiplex PCR reactions generated both C2-V3env amplicons
as well as LTR-gag amplicons, all of which were identical (Table 5, Figs 9C and 10A). Remark-
ably, these amplicons contained a signature 469 bp deletion that removed the packaging site,
the major splice site and the gag start codon, effectively inactivating the virus (Fig 10A). We
as a conservative estimate of the ratio. Data from 11 uninfected cord blood experiments. Mean ± standard deviation is
indicated; n3 for each envelope. Results were compared to infection by VSV-G pseudotyped viruses and p values were
determined using 2-tailed Student’s t-test (***p<0.001, ****p<0.0001). C. Data from B but compiled by tropism.
Mean ± standard deviation is indicated; one-way ANOVA, p<0.0001, with Tukey’s Multiple Comparisons Test indicated
(***p<0.001 and ****p<0.0001).
https://doi.org/10.1371/journal.ppat.1006509.g006
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Fig 7. CD4high HSPCs include progenitors with multi-lineage potential. A. Representative flow plots of
Sort 1 and Sort 2 bone marrow-derived HSPCs sorted using fluorescence activated cell sorting into CD4high
and CD4low/- subsets. B and C. Sorted HSPCs were analyzed by methylcellulose colony formation assays.
Mean ± standard deviation is indicated for counts from three blinded investigators; 2-tailed Student’s t-test
(*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). CFU-E, erythroid; CFU-GM, granulocyte/macrophage and
CFU-GEMM, multilineage.
https://doi.org/10.1371/journal.ppat.1006509.g007
HIV infection of hematopoietic progenitors
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006509 July 21, 2017 16 / 30
Fig 8. CD4high HSPCs include progenitors with multi-lineage potential. A. Flow cytometric analysis of differentiation markers expressed on
bone marrow HSPCs purified as described in Fig 1A. For the two right-most panels, numbers indicate percentage of total CD34+ events in each
sort falling into that gate. B. Summary table of frequencies for each phenotypic gate as shown in A. Lineage outputs based upon Doulatov et al
[9]. (Abbreviations: HSC, hematopoietic stem cell; MPP, multipotent progenitor; MLP, multilymphoid progenitor; CMP, common myeloid
progenitor; MEP, megakaryocyte/erythrocyte progenitor; GMP, granulocyte/monocyte progenitor; B-NK, B and NK cell progenitor; MDC,
macrophage and dendritic cell; EMK, erythroid and megakaryocyte) C. Summary graphs depicting the percentage of each subset of the total
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confirmed that the deleted gag came from the same proviral genome as the C2-V3env ampli-
cons by using SGA PCR to isolate two near-full-length genome amplicons from CD4-negative
cells (Fig 10A). The presence of replication defective clonal proviral genomes in multiple dif-
ferentiated hematopoietic lineages and in HSPCs provides strong evidence that infected multi-
potent progenitors persist and differentiate in optimally treated people.
A phylogenetic analysis of all donor sequences ensured that all donor 431 sequences clus-
tered together, ruling out contamination and cross contamination as confounding factors (S1
Fig). Moreover, phylogenetic analysis revealed that amplicons isolated from CD4-negative cells
(B, NK and CD8) were not common in CD4+ cells or unfractionated PBMCs, making cross-
contamination an unlikely explanation for their relatively high frequency in CD4-negative line-
ages (Fig 9B and 9C). Further, we used previously described statistical analysis [10] to demon-
strate that the LTR-gag amplicons from B and NK cells were unlikely to have come from
contaminating CD8+ T cells [p<0.05 (1)].
CD34+ cells in each sort. Cells were isolated from cord blood (n = 5, circles) or bone marrow (n = 2, squares). For three experiments (2 cord
blood and 1 bone marrow), lineage-positive cells were physically or analytically excluded from analysis (open symbols). Mean ± standard
deviation is indicated; 2-tailed Student’s t-test (*p<0.05, ***p<0.001, ****p<0.0001).
https://doi.org/10.1371/journal.ppat.1006509.g008
Table 5. HIV isolation from CD4-negative lineages from a subset of ten donors.
CXCR4 No CXCR4
Donor: 409 413 420 428 432 415 419 431 434 435
CD8 CD8+ (%) 100 100 97 99 97 97 99 96 98 98
CD3+CD4+ (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cells Analyzed (x104) 100 100 100 90 100 100 100 158 100 100
Rxn 20 20 20 18 20 20 20 40 20 20
LTR-gag 0 1* 3* 2**** 1* 0 0 1****,7**** 0 0
C2-V3 0 0 1* (X4) 0 0 0 0 11****# (R5) 0 0
B CD19+ (%) 97 97 99 98 77 96 84 87 98 94
CD3+CD4+ (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1
Cells Analyzed (x104) 100 90 140 140 82 100 44 93 100 100
Rxn 20 20 30 36 20 20 20 20 25 33
LTR-gag 0 0 0 0 0 0 0 1**,1** 0 0
C2-V3 0 0 0 0 0 0 0 2**# (R5) 0 0
NK CD56+ (%) 78 96 89 93 63 84 84 80 96 95
CD3+CD4+ (%) 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Cells Analyzed (x104) 99 100 120 63 54 100 62 100 100 62
Rxn 20 20 21 20 16 20 20 22 20 20
LTR-gag 0 0 2*# 0 0 0 0 1**,1** 0 0
C2-V3 0 0 0 0 2** (X4) 0 0 1*# (R5) 0 0
Asterisks indicate the likelihood the amplicon did not come from contaminating CD3+CD4+ T cell DNA. p values were determined as described in Fig 2.
*p< 0.05 by (1) only
**p< .05 by (1) and (2)
****p< .001 by (1) and (2) where (2) is the more conservative analysis.
# indicates amplicons identical to HSPC amplicons
Grey highlights detected provirus and underlines indicate amplicons identical to other CD4-negative amplicons from the same donor.
LTR-gag or C2-V3 refers to amplicon type.
Rxn indicates number of reactions performed.
https://doi.org/10.1371/journal.ppat.1006509.t005
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Fig 9. Evidence for transmission of proviral genomes from multipotent CD4+ HSPCs to differentiated peripheral blood cells. A.
Flow cytometric plots showing purity of CD4-negative lineages containing provirus identical to HSPC-derived provirus. “Pre” indicates the
cell population post CD4-bead depletion and prior to fluorescence activated cell sorting (FACS). “Post” indicates the cell populations
following FACS. Numbers in the upper right corner indicate the frequency of cells in that quadrant. The frequency of CD4+ cells that were
also CD3+ by gating was 0% (see also Table 5). B and C. Phylogenetic trees showing genetic relationships amongst amplicons. HIV RNA
shown is cell-associated (Fig 10B). Arrows indicate location of identical amplicons shown in Fig 10. Red lines indicate identical sequences.
Scale indicates nucleotide substitutions per site. ACH2, 89.6, BaL, YU-2, HXB2 and NL4-3 are subtype B HIVs. 84ZR085 (84ZR) and
94UG114 (94UG) are subtype D HIV molecular clone outgroups [32]. Phylogenetic analysis was performed by maximum likelihood method
using MEGA7[33] and history was inferred based on the Hasegawa-Kishino-Yano model [34]. The tree with the highest log likelihood is
shown. Abbreviations: PBMC, unfractionated peripheral blood mononuclear cells; BMMC, bone marrow mononuclear cell (column flow-
through).
https://doi.org/10.1371/journal.ppat.1006509.g009
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Fig 10. Identical HIV proviral genomes in CD4-negative progeny. A and C. Diagrammatic representation of clonal, defective proviral
genomes from the indicated donor 431000 cell types. Colored bars indicate regions of identity. Dotted lines indicate location of deletion.
White space indicates region where no sequence information is available. mRNA is cell associated from part B. B, (upper panel) Flow
cytometric analysis of purified CD4-negative and CD4+ populations isolated from donor 431000 PBMCs. (Lower panels) Summary graphs of
HIV-1 RNA isolated from supernatant (left) and cells (right) following treatment with PMA and ionomycin. Dashed line indicates limit of
detection. *p<0.05 D and E. Provirus found in CD4-negative progeny can be recovered in two independent donations separated by months.
D. Flow cytometric plots showing purity of CD4-negative lineages. “Pre” indicates the cell population post CD4-bead depletion and prior to
fluorescence activated cell sorting (FACS). “Post” indicates the cell populations following FACS. Numbers in the upper right corner indicate
the frequency of cells in that quadrant. The frequency of CD4+ cells that were also CD3+ by gating was 0% (see also Table 5). E.
Phylogenetic tree showing genetic relationships amongst amplicons from two separate donations (408 and 428). Arrow indicates location of
identical 693 bp gag amplicon from CD8 cells. (The region of identity extended through the non-translated LTR region of the amplicon, which
was not included in the phylogenetic analysis.) Red lines indicate identical sequences. Scale indicates nucleotide substitutions per site. 89.6,
BaL, YU-2, HXB2 and NL4-3 are subtype B HIVs. 84ZR085 (84ZR) and 94UG114 (94UG) are subtype D HIV molecular clone outgroups
[32]. Phylogenetic analysis was performed by maximum likelihood method using MEGA7 [33] and history was inferred based on the
Hasegawa-Kishino-Yano model [34]. The tree with the highest log likelihood is shown. Abbreviations: PBMC, unfractionated peripheral
blood mononuclear cells; BMMC, bone marrow mononuclear cell (column flow-through).
https://doi.org/10.1371/journal.ppat.1006509.g010
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CD4-negative lineages containing a deleted provirus transcribe RNA containing the
deletion but cannot produce infectious virus. To confirm that the provirus described in Fig
9 was inactive, and could not have spread to other cells through viral infection, we separated
CD4-negative and positive cells (Fig 10B, upper panels), activated them with PMA and iono-
mycin and measured virus released into the supernatant. As shown in Fig 10B, lower left panel,
CD4-negative peripheral blood cells harboring the defective provirus did not generate detect-
able virus in the supernatant following stimulation ex vivo, whereas CD4+ cells did. However,
HIV RNA containing the identical deleted sequence shown in 10A was isolated from the
CD4-negative cells (Fig 10B, lower right panel), confirming they contained the defective provi-
rus (Figs 9C and 10A). Demonstration that the provirus in these cells was defective rules out
the possibility that they were coincidentally infected with similar viruses and indicates that
they most likely received the provirus via differentiation from a common progenitor cell.
CD4-positive cells also harbored a unique deleted provirus derived from a distinct
HSPC. CD4+ cells tested in parallel also generated HIV mRNA but not the same sequences
found in the CD4-negative cells. In addition to intact gag amplicons, one of the most promi-
nent mRNA species amplified from CD4+ cells contained a unique deletion that was not found
in CD4-negative cells and exactly matched provirus amplified from an HSPC (Figs 9C and
10C). In sum, these results provide evidence that HSPCs can transmit proviral genomes to
both CD4+ and CD4-negative cells through differentiation in vivo.
Proviral genomes isolated from CD4-negative hematopoietic lineages persist over
time. Finally, we isolated identical 831 bp 5’LTR-gag amplicons from CD4-negative CD8
cells from two donations separated in time by about four months (Fig 10D and 10E). While
these amplicons clustered with other sequences from this donor (S1 Fig), they were not
identical to any other sequences (Fig 10E, arrow). Compared to the nearest group of similar
sequences, there were 11 additional differences or a genetic distance of 0.12. Thus, these data
demonstrate that clonal sequences from CD4-negative lineages can be repeatedly isolated
from the same cell type and persist over time in vivo, providing confirmatory evidence that
pathways for infection of CD4-negative cells via infection of CD4+ progenitors exist in vivo.
Discussion
The identification and characterization of cell types harboring HIV genomes is crucial for the
development of strategies to promote clearance. HSPCs support both active and latent infec-
tion by HIV in vitro and in vivo [13, 18]. However, prior studies suggested a model in which
only CXCR4-tropic viruses, which infect long-lived HSCs would be capable of persisting in
vivo [3]. Here, we provide evidence that non-stem cell CD34+ progenitors infected by
CCR5-tropic viruses are also long-lived. Indeed, HIV provirus isolated from HIV-infected
people treated with cART for years was often CCR5-tropic and recoverable from HSPC popu-
lations that were depleted for stem cells. These unexpected results support recent studies show-
ing that non-stem cell progenitors can persist in vivo for years and provide evidence that they
may form a significant reservoir in HIV infected people.
We also provide strong evidence that progenitor cells, including multipotent progenitors,
harbor HIV receptors. These results are consistent with other studies investigating the lineage
potential of CD4 subsets using functional assays [16, 17, 19]. Two studies showed that CD34+
CD4high and CD4low/- populations include clonogenic progenitors and Louache et al further-
more demonstrated that CD34+ CD4+ HSPCs are enriched for long-term culture-initiating cells
[16, 17]. Another study extended these results using human fetal liver to show that CD34+CD4+
cells are able to engraft in an immunodeficient mouse, unlike CD34+CD4- cells [19]. In addition,
HIVs that require CD4 for entry are able to infect and express marker genes in HSCs based on a
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gold standard functional assay (stable engraftment and generation of all hematopoietic lineages)
[3]. Thus, CD4 and other HIV receptors are expressed on hematopoietic progenitors.
Preferential infection of the CD4high subset partially explains another study that was unable
to detect provirus in HSPCs from infected people [20]. In this study, flow cytometry was used
to isolate Lin−CD34+ CD4- cells, obtaining a mean purity of 76.7% that was substantially lower
than the samples described here (mean purity 94.1% for Sort 1 and 90.3% for Sort 2). Based on
the data presented here, removal of the CD4+ population would have removed the HSPC pop-
ulation most likely to be infected. In addition, this small study of 8 donors (3 initiating therapy
during chronic infection and 5 initiating therapy during acute infection) was underpowered to
detect provirus in HSPCs. The authors estimate that in these 8 patients, if proviral genomes
were present, their frequency would be 0.0003%–0.003% (upper 95% confidence bounds).
Given that 59% of our donors were positive and that the mean frequency of provirus in our
cohort was 2.4 copies per million cells (0.0002%; range 18 to< 0.8 copies per million cells), the
small study size and the small number of cells screened provide additional explanations for
why this and another similarly powered study [21] were negative.
Importantly, we isolated four near full-length genomes from HSPCs and a detailed analysis
of open reading frames and cis-acting elements revealed they are likely to be functional. How-
ever, demonstration of functional virus using viral outgrowth assays will require additional
studies using larger cell numbers. Studies in T cells have shown that only about a tenth of func-
tional virus can be detected in outgrowth assays [22]. A Poisson analysis using a mean fre-
quency of 3 copies of provirus per million HSPCs with 30% functional based on sequencing
suggests 60 million HSPCs will be needed for 95% certainty of detecting one infectious unit.
Given that we obtain about 2.5 million HSPCs for each donor from 20 cc of marrow, we would
need to dramatically increase our aspiration size to acquire sufficient cells, which would not be
easy to accomplish because of patient discomfort. The low rate of infection in HSPCs likely
explains why an earlier study utilizing low numbers of HSPCs (approximately one million)
yielded negative results in outgrowth assays [21]. In addition, while we have shown that tran-
scriptionally latent viral genomes in HSPCs can be reactivated by TNFα and histone deacety-
lase inhibitors in vitro after cell culture [3, 13], studies using large cell numbers are needed to
determine the optimal strategies to effectively reactivate proviral genomes to promote viral
release from fully quiescent HSPCs tested ex vivo.
Nevertheless, the conclusion that HIV indeed infects HSPCs was confirmed by the detec-
tion of clonal HIV proviral genomes in differentiated lineages that matched provirus from
HSPCs. Because the differentiated cells were CD4-negative lineages and because the provirus
contained signature inactivating deletions, these results can’t be explained by coincident infec-
tion. Moreover, we confirmed the presence of these genomes by isolating cell-associated
mRNA containing the same deletion from activated CD4-negative cells. Further, we showed
by phylogenetic analysis that the genomes frequently isolated from CD4-negative lineages
formed a unique clonal population within the donor, indicating that contamination from
other cell types was an unlikely explanation of our findings. In sum, the most likely explana-
tion is that these genomes were transmitted to CD4-negative progeny through differentiation
of a CD4-positive progenitor. In addition, we also detected a proviral genome with a unique
signature deletion in both HSPC and CD4+ cells indicating that infected HSPCs can also dif-
ferentiate into CD4+ cells.
In most cases, detection of proviral genomes in CD4-negative lineages was rare with only a
small number of proviral genomes detected per million cells screened. The exception was
donor 431000 in which we detected a defective provirus at a higher frequency (approximately
one per 100,000 cells screened). Because replication competent virus could disrupt differentia-
tion due to cytopathic effects, it is not surprising that viral spread from differentiating HSPCs
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would be uncommon with functional virus, occurring at a higher frequency in cells harboring
a defective viral genome that might allow normal differentiation to occur.
In addition, we detected proviral genomes more often in CD4-negative lineages from
donors with CXCR4-tropic virus, consistent with its ability to target a wider range of HSPC
subtypes, including MPPs and HSCs. With the exception of one donor (431000), we did not
find CCR5-tropic provirus in differentiated CD8, B and NK lineages found in the peripheral
blood, which is consistent with observations that CCR5-tropic HIV more commonly infects
restricted myeloid progenitor cells [4].
Although HSCs are the main drivers for reconstitution of all hematopoietic lineages in
xenograft models, new insights in animal and human disease models have shown contribu-
tions of non-stem cell progenitors to steady state hematopoiesis over long periods of time [6–
8]. Non-stem cell progenitors appear to survive longer than previously thought in the bone
marrow without contribution from HSCs, with non-stem cell clones sequentially recruited
over time to produce mature blood cells [6–8, 23, 24]. Our data that CCR5-tropic provirus per-
sists for years in non-stem cell progenitors is to our knowledge the first evidence that non-
stem cell progenitors persist for years in humans without evidence of bone marrow disease.
Given that non-stem cell progenitors persist, the prevalence of CCR5-tropic HIV in this
compartment is not surprising. During acute infection when circulating virus peaks, the
majority of virus is CCR5-tropic [25]. However, we also detected persistent provirus that
encodes Env proteins capable of utilizing CXCR4 to enter cells. Assuming transmitting virus is
nearly uniformly CCR5-tropic, as some studies have indicated, the presence of persistent reser-
voirs of CXCR4-tropic provirus may indicate that reservoirs continue to form during evolu-
tion to CXCR4 tropism in some donors.
Overall, these results support a new model in which non-stem cell progenitors are impor-
tant long term contributors to normal hematopoiesis and moreover that these cells can serve
as a persistent reservoir for HIV provirus.
Materials and methods
Ethics statement
HIV-infected individuals were recruited through the University of Michigan HIV-AIDS Treat-
ment Program and the Henry Ford Health System. Written informed consent was obtained
according to a protocol approved by the University of Michigan Institutional Review Board
and Henry Ford Institutional Review Board (U-M IRB number HUM00004959 and HFH IRB
number 7403). Donors were >18 years old, with normal white blood cell counts and plasma
viral loads were <48 copies/ml for at least 6 months on antiretroviral therapy. 100 ml of
peripheral blood and 20 ml of bone marrow were obtained from each donor. All collected sam-
ples were coded.
Whole umbilical cord blood (CB) from uninfected donors was obtained from the New
York Blood Center and whole bone marrow was obtained commercially (AllCells Ltd.). All
collected samples were anonymized.
Cell isolation and fractionation
For isolation of HSPCs, mononuclear cells were purified by Ficoll-Hypaque centrifugation
and adherence depleted in serum-free StemSpan medium (StemCell Technologies) for 1–2
hours at 37˚C. Sort 1 cells were isolated with a CD133 MicroBead Kit (Miltenyi Biotec) accord-
ing to the manufacturer’s protocol, using two sequential sorts for increased purity. (For dona-
tions 453000, and 454304, we used 1.5 times the recommended MicroBeads to increase yield.)
Sort 2 cells were isolated from the Sort 1 flow-through using EasySep Human CD34 Positive
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Selection Kit (StemCell Technologies) according to the manufacturer’s protocol, using two
sequential sorts. Where indicated, lineage-positive cells were depleted using the EasySep Line-
age Depletion Kit (StemCell Technologies) before proceeding to the CD133 magnetic sort.
CD4 negative PBMCs from the human donors described in the ethics statement were puri-
fied by depletion of CD4+ cells with MicroBeads (Miltenyi Biotec) according to the manufac-
turer’s protocol modified for a bead:cell ratio of 1.5:1 and passage over two sequential LS
magnetic columns. Depleted cells were stained and sorted as indicated in the text to remove
residual CD4+ cells on a MoFlo Astrios flow cytometer.
RNA isolation
Supernatant and cell associated RNA was extracted using TRIzol LS and TRizol reagents,
respectively according to the manufacturer’s protocols (Invitrogen) and converted to cDNA
using qScript cDNA Supermix or qScript Flex cDNA Kit according to manufacturer’s instruc-
tions (Quanta Biosciences). RNA from viral supernatants was quantified by real time PCR
using TaqMan Fast Mastermix (Applied Biosystems) on an Applied Biosystems 7300 thermo-
cycler using primers and probes as previously described [26] and used in SGA PCR described
below.
For gene expression analysis, bone marrow cells were isolated and harvested as described
[27]. RNA was extracted from 3x104 double-sorted cells from each cell population. RNAseq
was performed on the total RNA extracted from each cell population, adding equal amounts of
92 spiked-in RNA standards to each cell population. Since the amount of spiked-in RNA stan-
dards added to each sample was known, the relationship between RPKM (reads per kilobase
per million) values and the number of transcripts for each spiked-in RNA could be determined
by regression analysis [28]. RNAseq reads were aligned using Bowtie software [29] to NCBI
build 37 (mm9) of the mouse genome with the settings: -e 70 -k 1 -m 2—n 2. The RPKM for
each RefSeq gene and synthetic spike-in RNA was calculated using RPKM_count.py (v2.3.5)
counting only exonic reads (-e option). Loess regression from R affy package was used to
renormalize the RPKM values by using only the spike-in RNA to fit the loess with default
parameters. Only the spike-in RNAs whose abundance could be robustly quantified (RPKM
values 1) were used in the loess normalization.
SGA PCR of patient samples
DNA was prepared using the MagNA Pure Compact System (Roche) and used at limiting dilu-
tion for a 2-step SGA PCR validated for single copy sensitivity on ACH-2 cell DNA using
primer sets shown in S5 Table. PBMC DNA from each donor was used to select the optimal
primer sets for each donor. PCR assays were performed using a BioRad C1000 thermocycler as
described in S6 Table. Amplicons were sequenced directly from the purified gel band.
Virus infection
Virus was prepared by transfection of HIV or lentiviral genome containing plasmids into
293T (ATCC) cells as described [13]. Where indicated, the helper plasmid pCMV-HIV-1[30]
and a plasmid encoding either VSV-G protein or an HIV envelope protein were used as
described previously [3, 31]. Intracellular Gag staining was performed as previously described
[13].
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Determination of Env phenotype
Env expression vectors were generated using gel purified DNA cloned into pcDNA3.1/
V5-His-TOPO TA. For phenotypic analysis of donor Env matching the HSPC V3 region, we
used 3T3-CD4-CCR5 and CXCR4 cells (NIH AIDS Reagent Repository) [11] transduced with
HIV-7/SF-GFP pseudotyped with the each Env and harvested for flow cytometry 3 days post-
transduction.
Antibodies used for flow cytometry
Antibodies to the following human proteins were used for flow cytometry: CD133 (phycoery-
thrin [PE] conjugated; Miltenyi Biotec), CD34 (conjugated with fluorescein isothiocyanate
[FITC], allophycocyanin [APC], PE-Cy7; Miltenyi Biotec and eBioscience), CD3 (APC;
eBioscience or APC-H7-conjugated; BD Bioscience), CD4 (clone OKT4, unconjugated, Bril-
liant Violet 605 conjugated; BD Biosciences or AlexaFluor488 conjugated; eBioscience),
CD45RA (APC conjugated; eBioscience), CD38 (PE-Cy7 conjugated; eBioscience), CD10
(Biotin conjugated; eBioscience), HIV-1 Gag (clone KC57, FITC conjugated; Beckman Coul-
ter), CD8 (PE conjugated; BioLegend), CD19 (APC conjugated; BD Bioscience), CD56
(PE-Cy7 conjugated; eBioscience).and Human Hematopoietic Lineage Cocktail (FITC conju-
gated; eBioscience). The secondary reagents used were streptavidin (Brilliant Violet 421 conju-
gated; BD Biosciences) and anti-mouse IgG2b (Alexa Fluor 647 conjugated; Invitrogen). Non-
viable cells were identified and excluded from sorts and analyses by staining with 7-aminoacti-
nomycin D (7-AAD) or DAPI. Samples were analyzed using a BD FacsCanto cytometer. Cell
sorting was performed using a MoFlo XDP (Beckman Coulter), MoFlo Astrios (Beckman
Coulter), FACSJazz (BD Biosciences) or FACSAria (BD Biosciences) flow cytometer.
For flow cytometric analysis and isolation of specific murine hematopoietic progenitors for
RNA isolation, cells were incubated with combinations of antibodies to the following cell-sur-
face markers conjugated to FITC, PE, PerCP-Cy5.5, APC, PE-Cy7, or biotin: CD3ε (17A2),
CD4 (GK1.5), CD5 (53–7.3), CD8α (53–6.7), CD11b (M1/70), CD16/32 (FcYRII/III; 93),
CD34 (RAM34), CD43 (1B11), CD45R (B220; RA3-6B2), CD48 (HM48-1), CD117 (c-kit;
2B8), CD127 (IL7Rα; A7R34), CD150 (TC15-12F12.2), Ter119 (TER-119), Sca1 (D7, E13-
161.7), Gr-1 (RB6-8C5), and IgM (II/41). For isolation of CD150+CD48-Lineage-Sca-1+c-kit+
(CD150+CD48-LSK) HSCs and CD150-CD48-LSK MPPs, lineage markers included CD3,
CD5, CD8, B220, Gr-1, and Ter119. For isolation of CD34+CD16/32lowCD127-Sca-1-LK
CMPs and CD34+CD16/32highCD127-Sca-1-LK GMPs, these lineage markers were supple-
mented with antibodies against CD4 and CD11b. Other sorted populations included Gr-1+
cells, IgM-CD43+B220+ pro-B cells, IgM-CD43-B220+ pre-B cells, and unfractionated bone
marrow cells.
Supporting information
S1 Fig. Phylogenetic trees showing genetic relationships amongst donor gag and env
(C2-V3) amplicons. 89.6, BaL, YU-2, HXB2, ACH2 and NL4-3 are subtype B HIVs. 84ZR085
(84ZR) and 94UG114 (94UG) are subtype D HIV molecular clone outgroups [32].
(TIF)
S2 Fig. Frequency of HIV proviral genomes in purified HSPCs does not correlate with
CD3+ T cell frequency. Linear regression analysis showing the lack of a correlation between
CD3+ T cell contamination and proviral frequency (R square values were 0.05 and 0.0008 for
Sort 1 and Sort 2 respectively). The number of cells analyzed for purity assessment for each
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donor is summarized in S4 Table. (To ensure rigor, samples containing >1% CD3+ T cells
were excluded.)
(TIF)
S3 Fig. CD3+ T cell contamination can’t explain HIV amplicons isolated from purified
HSPCs from donor 413402. Agarose gel analysis of rearranged TCRβ amplicons generated
from 5000 cell equivalents of DNA from first round PCR reactions [35]. The expected size of
the amplicons is 250–300 bp and the faint band in Sort 1 lane 7 could not be verified as TCRβ
by sequencing analysis. NT, No template; 293, control human embryonic kidney cell line
(1000 cells); M, DNA ladder. Numbers indicate number of CD4+ T cells added to positive con-
trol reactions.  indicates samples containing HIV DNA based on PCR analysis. The overall
frequency of HIV DNA detected in the flow-through sample from this donor was approxi-
mately 1 per 10,000 cells.
(TIF)
S1 Table. HSPC purity and assessment of T cell contamination for multiplex gag/C2env
SGA PCR. P values shown indicate the likelihood that amplicons did not originate from
contaminating T cell DNA. p values were determined either using a mean cell estimate or a
conservative estimate as in McNamara et al (ref. 10). The conservative estimate compared
the top of the 95% confidence interval for the calculated infection rate in CD3+ T cells in the
HSPC-depleted sample with the bottom of the 95% confidence interval for the calculated infec-
tion rate in CD3+ T cells in the HSPC-sorted sample to minimize the difference between these
calculated infection rates. First 3 digits is donation number; subsequent groups of 3 digits are
ID of previous donation(s) from the same individual, if any. Bold borders indicate multiple
donations from the same individual. Gray boxes indicate samples that did not meet criteria for
purity based on CD3%>1.0 or <80% HSPC (CD34 or CD133). Abbreviations: NA, not ana-
lyzed.
(PDF)
S2 Table. C2-V3 amplicon screen of first round reactions using whole genome primers and
analysis of T cell contamination. P values shown indicate the likelihood that amplicons did
not originate from contaminating T cell DNA. p values were determined either using a mean
cell estimate or a conservative estimate as in McNamara et al (ref. 10). The conservative esti-
mate compared the top of the 95% confidence interval for the calculated infection rate in
CD3+ T cells in the HSPC-depleted sample with the bottom of the 95% confidence interval for
the calculated infection rate in CD3+ T cells in the HSPC-sorted sample to minimize the differ-
ence between these calculated infection rates. First 3 digits is donation number; subsequent
groups of 3 digits are ID of previous donation(s) from the same individual, if any. Bold borders
indicate multiple donations from the same individual. Gray boxes indicate samples that did
not meet criteria for purity based on CD3%>1.0 or <80% HSPC (CD34 or CD133). Abbrevia-
tions: NA, not analyzed.
(PDF)
S3 Table. Cis elements in donor near-full-length genomes. Amplicons correspond to
HXB2 positions 604–9599 and “-”indicates region not amplified. “Y” indicates identity to
HXB2, red indicates differences and lower case denotes insertions. pbs, tRNA primer binding
site; SL, packaging stem loop; DIS, dimerization initiation site; MSD, major splice donor.
(Sequences and locations from HIV Sequence Compendium 2015, Los Alamos National Lab-
oratory.).
(PDF)
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S4 Table. Number of cells analyzed by flow for purity.
(PDF)
S5 Table. PCR primer sequences.
(PDF)
S6 Table. PCR cycling conditions. Conditions optimized for 1st round of multiplex PCR
with gag primers (U5-577.9662-f plus tagD4.6b-p24R1d plus or minus long1316-D4.6b).
(PDF)
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